Monday, December 1, 2008
pehel.com
Home Latest News Pakistan World Science / Technology Sports Entertainment Health Business


Cortex's AMPAKINE Compound, CX717, Achieves Primary Endpoints In 2nd Phase IIa Respiratory Depression Study In Germany
Source: Medical News Today E-Mail this News Story to a friend E-Mail this Story
Category: Health
Publication Date: Mon, 06 Oct 2008 10:00:00 PDT
News URL: http://www.medicalnewstoday.com/articles/124374.php
Cortex's AMPAKINE Compound, CX717, Achieves Primary Endpoints In 2nd Phase IIa Respiratory Depression Study In GermanyCortex Pharmaceuticals, Inc. (NYSE Alternext US (COR)) reported that top-line data from its second Phase IIa study in opioid-induced respiratory depression (RD) demonstrated that a single oral dose of 1500mg of the AMPAKINEŽ compound CX717 achieved statistical significance (p = 0.
Click here for full Story
http://www.medicalnewstoday.com/articles/124374.php
Bookmark this news story online:
Add Cortex's AMPAKINE Compound, CX717, Achieves Primary Endpoints In 2nd Phase IIa Respiratory Depression Study In Germany to BlinkListAdd Cortex's AMPAKINE Compound, CX717, Achieves Primary Endpoints In 2nd Phase IIa Respiratory Depression Study In Germany to DeliciousAdd Cortex's AMPAKINE Compound, CX717, Achieves Primary Endpoints In 2nd Phase IIa Respiratory Depression Study In Germany to DiggAdd Cortex's AMPAKINE Compound, CX717, Achieves Primary Endpoints In 2nd Phase IIa Respiratory Depression Study In Germany to FarkAdd Cortex's AMPAKINE Compound, CX717, Achieves Primary Endpoints In 2nd Phase IIa Respiratory Depression Study In Germany to FurlAdd Cortex's AMPAKINE Compound, CX717, Achieves Primary Endpoints In 2nd Phase IIa Respiratory Depression Study In Germany to BlogarithmAdd Cortex's AMPAKINE Compound, CX717, Achieves Primary Endpoints In 2nd Phase IIa Respiratory Depression Study In Germany to MeneameAdd Cortex's AMPAKINE Compound, CX717, Achieves Primary Endpoints In 2nd Phase IIa Respiratory Depression Study In Germany to My Yahoo!Add Cortex's AMPAKINE Compound, CX717, Achieves Primary Endpoints In 2nd Phase IIa Respiratory Depression Study In Germany to ReddItAdd Cortex's AMPAKINE Compound, CX717, Achieves Primary Endpoints In 2nd Phase IIa Respiratory Depression Study In Germany to ShadowsAdd Cortex's AMPAKINE Compound, CX717, Achieves Primary Endpoints In 2nd Phase IIa Respiratory Depression Study In Germany to SimpyAdd Cortex's AMPAKINE Compound, CX717, Achieves Primary Endpoints In 2nd Phase IIa Respiratory Depression Study In Germany to SpurlAdd Cortex's AMPAKINE Compound, CX717, Achieves Primary Endpoints In 2nd Phase IIa Respiratory Depression Study In Germany to Sync2ItAdd Cortex's AMPAKINE Compound, CX717, Achieves Primary Endpoints In 2nd Phase IIa Respiratory Depression Study In Germany to MagnoliaAdd Cortex's AMPAKINE Compound, CX717, Achieves Primary Endpoints In 2nd Phase IIa Respiratory Depression Study In Germany to NewsVineAdd Cortex's AMPAKINE Compound, CX717, Achieves Primary Endpoints In 2nd Phase IIa Respiratory Depression Study In Germany to Ask Jeeves
Add Cortex's AMPAKINE Compound, CX717, Achieves Primary Endpoints In 2nd Phase IIa Respiratory Depression Study In Germany to Raw SugarAdd Cortex's AMPAKINE Compound, CX717, Achieves Primary Endpoints In 2nd Phase IIa Respiratory Depression Study In Germany to DiigoAdd Cortex's AMPAKINE Compound, CX717, Achieves Primary Endpoints In 2nd Phase IIa Respiratory Depression Study In Germany to NetVouzAdd Cortex's AMPAKINE Compound, CX717, Achieves Primary Endpoints In 2nd Phase IIa Respiratory Depression Study In Germany to Stumble UponAdd Cortex's AMPAKINE Compound, CX717, Achieves Primary Endpoints In 2nd Phase IIa Respiratory Depression Study In Germany to SegnaloAdd Cortex's AMPAKINE Compound, CX717, Achieves Primary Endpoints In 2nd Phase IIa Respiratory Depression Study In Germany to Google BookmarksAdd Cortex's AMPAKINE Compound, CX717, Achieves Primary Endpoints In 2nd Phase IIa Respiratory Depression Study In Germany to Microsoft LiveAdd Cortex's AMPAKINE Compound, CX717, Achieves Primary Endpoints In 2nd Phase IIa Respiratory Depression Study In Germany to BlogMarksAdd Cortex's AMPAKINE Compound, CX717, Achieves Primary Endpoints In 2nd Phase IIa Respiratory Depression Study In Germany to WinkAdd Cortex's AMPAKINE Compound, CX717, Achieves Primary Endpoints In 2nd Phase IIa Respiratory Depression Study In Germany to TechnoratiAdd Cortex's AMPAKINE Compound, CX717, Achieves Primary Endpoints In 2nd Phase IIa Respiratory Depression Study In Germany to Feed Me LinksAdd Cortex's AMPAKINE Compound, CX717, Achieves Primary Endpoints In 2nd Phase IIa Respiratory Depression Study In Germany to LinkaGoGoAdd Cortex's AMPAKINE Compound, CX717, Achieves Primary Endpoints In 2nd Phase IIa Respiratory Depression Study In Germany to BlueDotAdd Cortex's AMPAKINE Compound, CX717, Achieves Primary Endpoints In 2nd Phase IIa Respiratory Depression Study In Germany to Mister WongAdd Cortex's AMPAKINE Compound, CX717, Achieves Primary Endpoints In 2nd Phase IIa Respiratory Depression Study In Germany to TailRankAdd Cortex's AMPAKINE Compound, CX717, Achieves Primary Endpoints In 2nd Phase IIa Respiratory Depression Study In Germany to Yahoo Bookmarks

Comments

No comments found... be the first one to comment on this story :)

Post a Comment
Name:
   
E-Mail Address:
   
Website / Blog URL (optional):
   
Comments:
   
Security Code:
   
  
   By submitting these comments, you are agreeing to our Terms of Service
    
Latest News
Latest News World News Pakistan News Technology News Entertainment News Business News Sports News
bullet First Ever In-vivo Efficacy Data For A MicroRNA Therapeutic Disease Model
bullet Philips Unveils Two Major Innovations Designed To Help Radiologists Improve Patient Care
bullet Computer Virus Latest Information - Barts And The London NHS Trust, England
bullet Marshall Edwards, Inc. Files IND Application For Triphendiol - Locally Advanced Or Metastatic Pancreatic And Bile Duct Cancers
bullet New Data Provide Comprehensive Understanding Of Americans' Use Of Complementary And Alternative Medicine (CAM)
bullet Proteins That Assist Fracture Healing Causing Abnormal Bone Growth In Soft Tissues
bullet New Study Shows Potential Of Rational Drug Design In Schizophrenia
bullet Aging Not Slowed By Antioxidants, Study Rejects 50 Year Old Theory
bullet New Methods To Avoid Knee Replacements
bullet Institute Of Public Health To Launch Decent Food For All Evaluation Document, Ireland
bullet New Archiving Software Gives Clinicians Centralised Access To Data From Disparate PACS Systems
bullet On 1 December, The Union Observes The 20th Anniversary Of World AIDS Day And Addresses The Issues Of TB-HIV/AIDS Care
bullet Earlier Detection Of Cancer And Better Treatment For Survivors, UK
bullet AIDS Day: Successful Global HIV Testing Campaign To Test 1M People Marches On
bullet Stereotactic Breast Biopsy Made Easy With Mammomat Inspiration
bullet World Congress Against The Sexual Exploitation Of Children And Adolescents Comes To A Close In Brazil
bullet SAC Report Has Important Role To Play In Climate Change Policy Says Task Force
bullet AVMA Revises Policy On Ear Cropping And Tail Docking
bullet East London Getting Sexual Health Clinic Test Results By Text On Their Mobile Phones
bullet Brain Waves Show Sound Processing Abnormalities In Autistic Children
bullet Newly Reported HIV Cases On The Rise In Europe
bullet Exercise Helps Prevent Age-Related Brain Changes In Older Adults
bullet Improving Occupational Safety And Health Worldwide - International Conference To Be Held In Dresden In January 2009
bullet Lower Childhood IQ Associated With Higher Risk Of Adult Mental Disorders
bullet Antibiotics: Single Largest Class Of Drugs Causing Liver Injury
 
© 2007 Verge Systems